Engrail Therapeutics

📍 San Diego, United States🗓 Founded 2019👥 26 employees💰 Last funded Mar 2024
Pharmaceutical Manufacturing🌐 engrail.com
Website LinkedIn
We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Engrail Therapeutics?
Engrail Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Engrail Therapeutics last raise funding?
The most recent investment in Engrail Therapeutics recorded on gritt.io was in March 2024.
When was Engrail Therapeutics founded?
Engrail Therapeutics was founded in 2019.
What industry is Engrail Therapeutics in?
Engrail Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Engrail Therapeutics based?
Engrail Therapeutics is headquartered in San Diego, United States.